CAH - CONGENITAL ADRENAL HYPERPLASIA

Clinical trials for CAH - CONGENITAL ADRENAL HYPERPLASIA explained in plain language.

Never miss a new study

Get alerted when new CAH - CONGENITAL ADRENAL HYPERPLASIA trials appear

Sign up with your email to follow new studies for CAH - CONGENITAL ADRENAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New pill shows promise for controlling rare hormone disorder

Disease control Completed

This study tested whether a new oral medication called SPR001 could help adults with classic congenital adrenal hyperplasia (CAH) better control their hormone levels. Twenty-four participants took increasing doses of the pill over six weeks while researchers monitored safety and …

Matched conditions: CAH - CONGENITAL ADRENAL HYPERPLASIA

Phase: PHASE2 • Sponsor: Spruce Biosciences • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

CAH - CONGENITAL ADRENAL HYPERPLASIA

Get alerted when new CAH - CONGENITAL ADRENAL HYPERPLASIA trials appear

New pill shows promise for controlling rare hormone disorder